Table 2.
Effects of PKA on Vo at half-maximal activation
Animal groupTreatmentP/PoVH (in ML s−1)VL (in ML s−1)
WT Basal (4) 0.493 ± 0.017 2.0 ± 0.2 1.0 ± 0.1 
 PKA (4) 0.551 ± 0.029 2.9 ± 0.2a 1.9 ± 0.2a 
cTnIAla2 Basal (4) 0.585 ± 0.010 2.1 ± 0.2 1.0 ± 0.1 
 PKA (4) 0.575 ± 0.010 3.1 ± 0.3a 1.8 ± 0.1a 
cMyBP-C null Basal (5) 0.558 ± 0.050 4.5 ± 0.2  
 PKA (4) 0.572 ± 0.020 4.3 ± 0.1  
tWT Basal (5) 0.481 ± 0.038 2.0 ± 0.1 0.9 ± 0.1 
 PKA (4) 0.512 ± 0.036 3.5 ± 0.2a 1.8 ± 0.2a 
t3SA Basal (6) 0.518 ± 0.036 2.2 ± 0.1 1.1 ± 0.1 
 PKA (6) 0.526 ± 0.026 1.9 ± 0.2 1.1 ± 0.1 
t3SD Basal (6) 0.540 ± 0.042 3.1 ± 0.2 1.9 ± 0.2 
 PKA (5) 0.542 ± 0.052 3.9 ± 0.2a 1.9 ± 0.1 
Animal groupTreatmentP/PoVH (in ML s−1)VL (in ML s−1)
WT Basal (4) 0.493 ± 0.017 2.0 ± 0.2 1.0 ± 0.1 
 PKA (4) 0.551 ± 0.029 2.9 ± 0.2a 1.9 ± 0.2a 
cTnIAla2 Basal (4) 0.585 ± 0.010 2.1 ± 0.2 1.0 ± 0.1 
 PKA (4) 0.575 ± 0.010 3.1 ± 0.3a 1.8 ± 0.1a 
cMyBP-C null Basal (5) 0.558 ± 0.050 4.5 ± 0.2  
 PKA (4) 0.572 ± 0.020 4.3 ± 0.1  
tWT Basal (5) 0.481 ± 0.038 2.0 ± 0.1 0.9 ± 0.1 
 PKA (4) 0.512 ± 0.036 3.5 ± 0.2a 1.8 ± 0.2a 
t3SA Basal (6) 0.518 ± 0.036 2.2 ± 0.1 1.1 ± 0.1 
 PKA (6) 0.526 ± 0.026 1.9 ± 0.2 1.1 ± 0.1 
t3SD Basal (6) 0.540 ± 0.042 3.1 ± 0.2 1.9 ± 0.2 
 PKA (5) 0.542 ± 0.052 3.9 ± 0.2a 1.9 ± 0.1 

All values are expressed as mean ± SEM, with the number of trabecular preparations listed in parentheses.

P/Po, relative Ca2+-activated force.

a

Significantly different from basal control.

or Create an Account

Close Modal
Close Modal